IBACR — IB Acquisition Corp.
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1998781 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -748,177 | -639,866 | 8,477,425 | 4,634 | 1,839,658 |
| Dec 2025 | 0 | 0 | -180,000 | -58,902 | 16,405,261 | 165,484 | 1,162,171 |
| Jun 2025 | 1,254,202 | 0 | -172,210 | 818,610 | 122,176,971 | 486,018 | 549,009 |
| Mar 2025 | 1,250,141 | 0 | -163,485 | 824,126 | 121,164,499 | 627,375 | 355,147 |
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 0 | -748,908 | 3,416,169 | 17,134,092 | 1,832,100 | 15,301,992 | — |
| Sep 2024 | 0 | -523,974 | 1,867,387 | 119,800,388 | 722,230 | 119,078,158 | — |
TTM Snapshot
Revenues TTM
$-2,621,671
NetIncome TTM
$986,207
OpCashFlow TTM
—
Assets (Latest)
$8,477,425
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IQV | IQVIA HOLDINGS INC. | $42.61B | $258.88 | — |
| IDXX | IDEXX LABORATORIES INC /DE | $40.43B | $513.14 | — |
| INCY | INCYTE CORP | $22.85B | $112.75 | — |
| MEDP | Medpace Holdings, Inc. | $16.82B | $602.70 | — |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $14.35B | $298.00 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.